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Essential requirement for caspase-8/FLICE in the initiation of the
Fas-induced apoptotic cascade
Peter Juo*, Calvin J. Kuo*†, Junying Yuan* and John Blenis*
Background: Fas (APO-1/CD95) is a member of the tumor necrosis factor
receptor (TNF-R) family and induces apoptosis when crosslinked with either
Fas ligand or agonistic antibody (Fas antibody). The Fas–Fas ligand system has
an important role in the immune system where it is involved in the
downregulation of immune responses and the deletion of peripheral
autoreactive T lymphocytes. The intracellular domain of Fas interacts with
several proteins including FADD (MORT-1), DAXX, RIP, FAF-1, FAP-1 and
Sentrin. The adaptor protein FADD can, in turn, interact with the cysteine
protease caspase-8 (FLICE/MACH/Mch5).
Results: In a genetic screen for essential components of the Fas-mediated
apoptotic cascade, we isolated a Jurkat T lymphocyte cell line deficient in
caspase-8 that was completely resistant to Fas-induced apoptosis.
Complementation of this cell line with wild-type caspase-8 restored Fas-
mediated apoptosis. Fas activation of multiple caspases and of the stress
kinases p38 and c-Jun NH2-terminal kinase (JNK) was completely blocked in
the caspase-8-deficient cell line. Furthermore, the cell line was severely
deficient in cell death induced by TNF-α and was partially deficient in cell death
induced by ultraviolet irradiation, adriamycin and etoposide.
Conclusions: This study provides the first genetic evidence that caspase-8
occupies an essential and apical position in the Fas signaling pathway and
suggests that caspase-8 may participate broadly in multiple apoptotic pathways.
Background
Fas — a member of the tumor necrosis factor receptor
(TNF-R) family — induces apoptosis when crosslinked
with either Fas ligand or agonistic antibody (Fas antibody)
[1–3]. Fas-mediated apoptosis has been implicated in the
downregulation of the immune response, the deletion of
peripheral autoreactive T lymphocytes and the mainte-
nance of sites of immune privilege [1,4]. Using two-hybrid
analysis, several groups have identified proteins that inter-
act with the intracellular domain of Fas, such as FADD
(MORT-1), DAXX, RIP, FAF-1, FAP-1 and Sentrin
[5–10]; however, the in vivo relevance of several of these
proteins is not clear. With the exception of FADD and
RIP, which have been homozygously deleted in mice
[11–13], the role of these proteins in Fas-induced death has
largely been inferred from overexpression studies [1,14].
Fas crosslinking activates several members of the caspase
family, cysteine proteases believed to mediate apoptosis
in response to diverse stimuli [1,15]. FADD interacts with
caspase-8 (FLICE/MACH/Mch5) [16,17], which can pro-
teolytically cleave and activate many other caspases
[18,19]. Since caspase-8 is recruited to the Fas complex
through the adaptor protein FADD and can autoactivate
upon oligomerization [20–24], caspase-8 could potentially
initiate the caspase cascade; however, direct evidence for
this has been lacking.
Multiple death pathways may potentially emanate from
the Fas and TNF-R complexes. Caspase-8 and caspase-10
are both recruited to Fas by interacting with FADD,
whereas DAXX binds directly to Fas, initiating a death
pathway independent of FADD [5–10,16,17,21–27]. In
addition, caspase-8 and caspase-10 can be recruited to the
TNF-R through FADD, and RAIDD/CRADD may bring
caspase-2 to the TNF-R complex through RIP
[16,17,25–29]. The contribution of each of these potential
death pathways to apoptosis induced by Fas and TNF-α
has not been well established.
We sought to identify genes involved in Fas-mediated
apoptosis in an unbiased manner by using a functional
genetic screen in mammalian cells. We isolated a cell line
deficient in the cysteine protease caspase-8 and have used
this cell line to dissect signaling events downstream of Fas.
Results
To identify genes functionally involved in Fas-mediated
apoptosis, we initiated a genetic screen in a physiologi-
cally relevant cell type, human Jurkat T lymphocytes. By 
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limiting dilution, we isolated a Jurkat subclone (A3) that
was exquisitely sensitive to killing with Fas antibody, with
a spontaneous resistance rate of < 1 × 10–7. 108 Jurkat A3
cells were then treated with three cycles of exposure to
the frameshifting mutagen ICR191, a method used suc-
cessfully by Stark and colleagues [30,31] to isolate clones
harboring recessive mutations. This resulted in the out-
growth of 20 mutant clones resistant to killing by Fas anti-
body, compared with only four spontaneous survivors in
108 nonmutagenized cells (unpublished observations).
The 20 ICR191-derived mutant clones were analyzed for
expression of various signaling molecules postulated to
function in Fas-mediated apoptosis. One of these clones
did not express caspase-8 (isoforms 8a and 8b) [32], as
determined by western blotting with an antibody directed
against the p20 subunit, and was completely resistant to
Fas-induced death (Figure 1a,c). This result suggests that
in Jurkat cells there are no other major parallel Fas death
pathways upstream of caspase-8. Other proteins implicated
in Fas-mediated apoptosis, such as caspase-10, DAXX,
SHP-1, FADD, Bcl-xL, Bcl-2 and RIP [5–10,28,33], were
expressed at wild-type levels in the caspase-8-deficient
cell line (Figure 1a and data not shown). In addition, the
mutant cells contained wild-type levels of Fas RNA and
cell-surface Fas as determined by fluorescence-activated
cell sorting (FACS) analysis (Figure 1a,b).
We believe that the genetic defect of our caspase-8-defi-
cient cell line is a frameshift mutation in the caspase-8
gene that results in an unstable truncated protein. Total
RNA was isolated from wild-type and mutant cells and
subjected to reverse transcription followed by the poly-
merase chain reaction (RT–PCR) using primers specific
for caspase-8; this was followed by in vitro transcription
and translation. A truncated caspase-8 protein was pro-
duced from RNA isolated from mutant but not wild-type
cells (data not shown). No bands corresponding to wild-
type caspase-8 were observed. When lysates from wild-
type and mutant cells were western blotted for caspase-8
protein expression, however, no caspase-8 protein was
observed in the mutant cells (Figure 1a). The same
caspase-8 antibody was able to recognize the truncated in
vitro translated caspase-8 protein, suggesting that the
epitope was intact and that the truncated caspase-8
protein was probably unstable in cells (data not shown).
The isolation of this caspase-8-deficient cell line allowed
us to investigate the role of this protein in vivo and in the
absence of overexpression.
To investigate the significance of the lack of caspase-8 in
our mutant cell line, we sought to rescue the mutant phe-
notype by functionally complementing the mutant cells
with wild-type caspase-8. Transfection of wild-type
caspase-8, but not empty vector, into the mutant rescued
the ability of Fas antibody to induce apoptosis (Figure 2).
In comparison, Fas antibody induced apoptosis of wild-
type cells whether they were transfected with empty
vector or wild-type caspase-8 (Figure 2). Some Fas-depen-
dent apoptosis is observed in the empty-vector-transfected
caspase-8 mutant cells. This cell death is probably due to
increased stress following the transfection procedure;
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Figure 1
Initial characterization of a cell line deficient in
caspase-8. (a) Lysates from wild-type and
caspase-8 mutant cells were western blotted
for caspase-8, caspase-10, DAXX, SHP-1,
FADD, Bcl-xL, Bcl-2 and MAP kinase. To
visualize Fas protein, RNA was isolated from
wild-type and caspase-8 mutant cells and
subjected to RT–PCR followed by in vitro
transcription and translation in the presence
of [35S]methionine. (b) Wild-type or caspase-
8 mutant cells were stained with anti-mouse
(IgG+IgM)–FITC alone (Boehringer
Mannheim; black line) or Fas antibody plus
anti-mouse (IgG+IgM)–FITC (solid black) and
analyzed for surface Fas expression by FACS.
Fluorescence intensity is given in arbitrary
units. (c) Wild-type (circles) or caspase-8
mutant (triangles) cells were either left
untreated (open symbols) or treated with Fas
antibody (solid symbols). The number of viable
cells was determined by trypan blue dye
exclusion. Data represent the
mean ± standard deviation (SD; n = 3). DNA
laddering was monitored to confirm apoptosis
and was detected only in wild-type cells
treated with Fas antibody (data not shown).
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however, the contribution of other minor caspase-8-inde-
pendent pathways cannot be formally excluded. These
results strongly suggest that caspase-8 deficiency is the
sole genetic lesion conferring resistance to Fas in the
mutant cells and provide the first functional genetic evi-
dence that caspase-8 is absolutely required for Fas-
induced apoptosis.
Upon Fas crosslinking, several downstream caspases are
proteolytically cleaved and activated, allowing them to
cleave other substrates [1,15]. To determine whether
caspase-8 serves as the ‘apical protease’ that initiates the
Fas-dependent caspase cascade, we compared caspase
activities in the mutant and wild-type cells in vitro. Consis-
tent with previous results [1,15,34], extracts from wild-type
cells treated with Fas antibody contained protease activities
capable of cleaving poly-(ADP-ribose) polymerase (PARP)
and caspase-2 in vitro (Figure 3a). In contrast, extracts from
caspase-8-deficient cells were unable to cleave PARP or
caspase-2 (Figure 3a). A trace amount of caspase activity
was observed in the caspase-8-deficient cell extracts treated
with Fas antibody only after prolonged (> 6 hours) incuba-
tion (Figure 3a); however, this in vitro activity did not corre-
spond to an apoptotic response (Figure 1c).
To confirm defective caspase activation of the mutant cells
in vivo, cleavage of several caspases and substrates was
assessed by western blotting. Fas antibody treatment of
wild-type cells resulted in the proteolytic cleavage and
presumed activation of caspases-2, -3 and -7 (Figure 3b,c).
Two caspase substrates, PARP and protein kinase C-δ
(PKC-δ), were also cleaved [35] (Figure 3b). In contrast,
Fas antibody treatment of caspase-8-deficient cells failed
to induce the proteolytic cleavage of any of the caspases or
substrates assayed (Figure 3b,c). Interestingly, although
caspase-10 is expressed in Jurkat cells it is not proteolyti-
cally cleaved and activated in wild-type cells treated with
Fas antibody, even at time points when PARP is effi-
ciently cleaved (Figure 3d). Mitogen-activated protein
(MAP) kinase expression was used as a control for protein
levels. These results provide in vivo evidence that caspase-
8 is required for Fas activation of caspases and position
caspase-8 at the apex of the Fas cysteine protease cascade.
We and others have previously shown that Fas crosslink-
ing activates the stress MAP kinases p38 and c-Jun NH2-
terminal kinase (JNK) in a caspase-dependent manner
[36–39]. We tested our caspase-8-deficient cell line for the
ability of Fas antibody to activate p38 and JNK. Fas anti-
body treatment increased p38 and JNK kinase activities
7–8-fold in the wild-type but not the mutant cells
(Figure 4), suggesting that caspase-8 is required for Fas
activation of these stress kinases. In contrast, osmotic
shock activation of p38 and JNK was completely intact in
both the wild-type and mutant cells (data not shown),
arguing against a nonspecific block in kinase activation.
TNF-R signaling may be mediated by the recruitment of
caspases-2, -8 and -10 [16,17,25–28,40]. We therefore eval-
uated the role of caspase-8 in TNF-α-dependent apopto-
sis. TNF-α is capable of inducing apoptosis in Jurkat T
lymphocytes only when added with cycloheximide.
Accordingly, TNF-α plus cycloheximide, but not cyclo-
heximide alone, readily induced apoptosis of wild-type
cells (Figure 5a). In contrast, TNF-α-induced apoptosis
was severely inhibited in the caspase-8-deficient cell line
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Figure 2
Complementation of the caspase-8 mutant cell line. Wild-type or
caspase-8 mutant cells were transfected with a surface marker, CD8,
and empty pRSV vector (1:3 ratio) or CD8 and pRSV–caspase-8 (1:3
ratio). Cells were either left untreated (–) or treated (+) with Fas
antibody for 12 h. Cells were stained with anti-CD8–FITC and
propidium iodide. Transfected, viable cells were identified by FACS on
the basis of CD8 expression and propidium iodide exclusion. The
number of viable, CD8-positive cells is expressed as a percentage
relative to the untreated controls. Data represent mean ± SD (n = 3).
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(Figure 5a), indicating a nearly complete dependence of
this process on caspase-8. The small amount of cell death
that occurred in the caspase-8-deficient cell line could be
attributed to the nonspecific action of cycloheximide
alone, although the recruitment of other caspases, such as
caspase-2 and caspase-10, to the TNF-R complex may
also play a role [26–28].
TNF-α induces the phosphorylation and degradation of
the cytoplasmic protein IκBα, and the subsequent nuclear
translocation and activation of the transcription factor NF-
κΒ [41]. This signal is transmitted from the TNF-R
complex through the adaptor protein TRADD and the
serine/threonine kinase RIP [13,29,42]. RIP appears to be
expressed at wild-type levels in the mutant cell line (data
not shown) and TNF-α-induced degradation of IκBα
occurred in both wild-type and mutant cell lines
(Figure 5b), suggesting that caspase-8 is not required for
signaling from TNF-α to NF-κB 
Several reports have reached the surprising conclusion
that DNA-damaging agents such as ultraviolet (UV) irradi-
ation and the chemotherapy agents adriamycin and etopo-
side utilize Fas to induce apoptosis [43–48]; this model
has recently been challenged, however, in FADD-null
fibroblasts and by studies using neutralizing Fas antibod-
ies [12,49–51]. We compared the ability of UV and the
DNA-damaging chemotherapy agents adriamycin and
etoposide to induce apoptosis in the wild-type versus the
caspase-8-mutant cell lines. UV-, adriamycin- and etopo-
side-induced apoptosis was partially inhibited (30–40%) in
the caspase-8-deficient cells relative to the wild-type cells
(Figure 6a–c). In contrast, staurosporine-induced cell
death occurred at the same rate in both wild-type and
mutant cells, arguing against a nonspecific block in apop-
tosis in the mutant (Figure 6d). These data suggest that
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Figure 3
Caspase-8 resides at the apex of the cysteine
protease cascade. (a) In vitro protease
assays. Cells were either left untreated (0) or
treated with Fas antibody for 2–6 h. Extracts
were prepared and incubated with in vitro
translated [35S]methionine-labeled substrates,
PARP or pro-caspase-2 for 1 h at 37°C. The
reaction was analyzed by SDS–PAGE
followed by fluorography. Untreated substrate
input (—) is also shown. Results are
representative of three experiments.
(b,c) Lysates from wild-type or caspase-8
mutant cells were prepared from cells either
left untreated (–) or treated with Fas antibody
for 2–6 h and western blotted with antibodies
that recognize (b) the cleaved products of
PARP, caspase-3 and PKC-δ or that
recognize (c) pro-caspase-7 and cleaved
caspase-7, pro-caspase-2 and MAP kinase.
The lower portion of the caspase-7 blot was
exposed three times longer than the top half.
(d) Lysates from wild-type or caspase-8
mutant cells were prepared from cells either
left untreated (–) or treated with Fas antibody
for 2–8 h and western blotted with antibodies
to pro-caspase-10, PARP (C2–10) and MAP
kinase. The lower portion of the PARP blot
was exposed three times longer than the top
half. Results are representative of at least two
experiments. Molecular weights in kDa are
indicated to the left.
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Figure 4
Fas activation of p38 and JNK requires caspase-8. Wild-type or
caspase-8 mutant cells were either left untreated (–) or treated (+)
with Fas antibody (250 ng/ml) for 4 h. Cell lysates were made and
subjected to immune complex kinase assays using antibodies specific
for p38 or JNK. Kinase activity was measured using a glutathione-S-
transferase–activating transcription factor-2 (GST–ATF2 1–109)
fusion protein as substrate. Fold activation was quantitated using a
PhosphorImager. Results are representative of three experiments.
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caspase-8 participates in, but is not essential for, UV-
induced and chemotherapy-induced apoptosis.
Discussion
The isolation of a caspase-8 mutant in a genetic screen for
genes involved in Fas-mediated apoptosis, the complete
resistance of this mutant to Fas-induced death, and our
ability to rescue the Fas-induced death by complementa-
tion with wild-type caspase-8 provides unbiased genetic
evidence that caspase-8 is required for Fas-mediated
apoptosis in Jurkat T lymphocytes (Figures 1,2). We also
provide evidence of an essential role for caspase-8 in
TNF-α-induced apoptosis. Previous reports have indi-
cated that multiple apoptotic pathways may emanate
from the Fas and TNF receptors [5–10,16,17,25–28,40].
Our study suggests that in Jurkat T lymphocytes there
are no major parallel apoptotic pathways induced by Fas
or TNF-R other than the caspase-8 pathway
(Figures 1c,5a). Interestingly, DAXX, caspase-2 and
caspase-10 were expressed at wild-type levels in our
mutant cell line; however, Fas did not appear to activate
caspase-10 in wild-type Jurkat cells (Figure 1a). There-
fore, DAXX and caspase-10 may participate in Fas-medi-
ated apoptosis, and caspase-2 and caspase-10 may
participate in TNF-R-mediated apoptosis in other cell
types. Alternatively, these proteins may be more relevant
for other death receptors.
We have used this caspase-8-deficient cell line to dissect
signaling events downstream of Fas. Fas activation of cas-
pases capable of proteolytically cleaving substrates PARP
and PKC-δ and of cleaving and activating caspases-2, -3
and -7 was completely blocked in the caspase-8 mutant
cells (Figure 3). These data suggest that caspase-8 is
required in vivo for Fas activation of multiple downstream
caspases and position caspase-8 at the apex of the Fas cys-
teine protease cascade (Figure 3). Because Jurkat cells
differ from primary T cells in many regards, it will be
interesting to compare our results with studies of caspase-
8-dependent signaling in primary cells.
Caspase-8 was also required for Fas activation of the stress
MAP kinases p38 and JNK (Figure 4), supporting data
from our laboratory and others that have previously shown
that Fas activation of the stress MAP kinases is caspase
dependent [36–39]. DAXX has been proposed to mediate
Fas activation of JNK in a FADD- and caspase-indepen-
dent manner [10]. The role of DAXX in p38 activation has
not yet been examined. Our data suggest that in Jurkat
cells, DAXX-mediated activation of JNK must require
caspase-8 or, alternatively, DAXX-mediated activation of
JNK may be more relevant in other cell types.
The involvement of the Fas signaling pathway in DNA-
damage-induced apoptosis has been controversial
[47–51]. We have demonstrated that caspase-8 may par-
ticipate broadly in apoptosis, as cell death induced by
DNA-damaging UV or chemotherapy agents (Figure 6)
was partially inhibited (30–40%) in the caspase-8 mutant.
This indicates that caspase-8 participates in, but is not
required for, DNA-damage-induced death and suggests
that there are at least two pathways leading from DNA
damage to apoptosis, one dependent on and one indepen-
dent of caspase-8.
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TNF-α-induced apoptosis is blocked in the caspase-8 mutant cells,
whereas TNF-α-induced IκBα degradation is intact. (a) Wild-type or
caspase-8 mutant cells were either left untreated, treated with
cycloheximide alone (CHX; 0.5 µg/ml) or treated with cycloheximide
and TNF-α (CHX + TNF; 50 ng/ml) for various amounts of time. The
number of dead cells was determined using trypan blue dye exclusion.
Results are presented as the average of two experiments. (b) Wild-
type or caspase-8 mutant cells were either left untreated (–) or treated
with TNF-α (10 ng/ml) for 5–30 min. Lysates were western blotted
with antibodies to IκBα or MAP kinase as a control. Results are
representative of two experiments.
Conclusions
This study provides the first genetic evidence that
caspase-8 is required for Fas-induced apoptosis. Fas acti-
vation of multiple caspases and of the stress kinases p38
and JNK was completely blocked in the caspase-8-defi-
cient cell line. These data provide in vivo evidence that
caspase-8 is required for Fas activation of multiple cas-
pases and position caspase-8 at the apex of the Fas cys-
teine protease cascade. Furthermore, this study suggests
that caspase-8 may participate broadly in apoptosis in
response to a variety of stimuli including soluble factors
such as Fas ligand and TNF-α and DNA-damaging
agents. As caspase-8 could potentially be recruited to
other ‘death receptors’, this study may also have important
implications for these novel signaling pathways.
Materials and methods
Antibodies and reagents
Rabbit polyclonal antibodies to MAP kinase have been described previ-
ously [52]. Rabbit polyclonal antibodies to p38 were raised against a
20-amino-acid peptide at the extreme carboxyl terminus of human p38
(Cocalico). Antibodies to caspase-7 (rat monoclonal) and caspase-8
(rat monoclonal) were generated against the p20 subunit. Antibodies
to DAXX (M112), PKC-δ (C20), caspase-2 (Ich-1L C20), JNK-1 (C17),
Bcl-xL (S-18), Bcl-2 (100) and IκBα (C21) were purchased from Santa
Cruz Biotechnology, antibodies to caspase-10 from Upstate Biotech-
nology, and anti-human Fas monoclonal antibody (CH11) from Kamiya
Biomedical. Antibodies to PARP and caspase-3 were a gift from Calvin
Roff (R&D Systems). Antibodies to SHP-1 were obtained from Trans-
duction Labs, antibodies to FADD from Pharmingen and antibodies to
PARP (C2-10) from Guy Poirier. Propidium iodide, cycloheximide,
trypan blue dye, staurosporine and etoposide were purchased from
Sigma. TNF-α was obtained from Genzyme. [35S]methionine and
[γ-32P]ATP were obtained from Amersham and New England Nuclear,
respectively.
Cell culture
Jurkat cells were cultured in RPMI 1640 (Sigma) supplemented with
10% heat-inactivated fetal bovine serum (FBS; Hyclone). Cells were
maintained in 5% CO2 at 37°C. Cells were seeded 24 h before an
experiment at 8 × 105 cells/ml in complete media.
RT–PCR and in vitro transcription and translation
RNA was isolated from cells using Trizol (Gibco). Reverse transcription
was performed using oligo(dT) primers (Superscript, Gibco) followed
by PCR using primers specific for Fas or FADD. The 5′ primers also
contained a T7 RNA polymerase promoter overhang [53]. In order to
visualize the protein products, the PCR products were purified using
GeneClean (Bio101), transcribed (T7 polymerase), translated, and
labeled with [35S]methionine (Amersham) in vitro using a TNT kit
(Promega). Labeled proteins were separated by SDS–PAGE.
Fas surface staining
Jurkat cells (5 × 105) were washed in 4–5 ml cold FACS wash (2%
FBS in phosphate-buffered saline; PBS) and incubated with anti-Fas
antibody (CH11; 1 µg/ml) in a total volume of 50 µl on ice for 45 min.
Cells were washed in 4–5 ml cold FACS wash and incubated with sec-
ondary antibody, anti-mouse (IgG+IgM)–FITC (Boehringer Mannheim)
(1:50) in 50 µl total volume on ice in the dark for 30 min. Cells were
washed in 4–5 ml cold FACS wash and then resuspended in 200 µl
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Figure 6
Apoptosis induced by DNA damage is
partially blocked in the caspase-8 mutant cell
line. (a,b) Wild-type and caspase-8 mutant
cells were treated with either (a) UV-C
(80 J/m2) or (b) etoposide (10 µg/ml). The
number of dead cells was determined by
propidium iodide uptake and FACS analysis.
Data are presented as the mean ± SD (n = 3).
Results are representative of two or three
experiments. (c,d) Cells were treated with
either (c) adriamycin (0.5 µg/ml) or
(d) staurosporine (1 µM) and viable cells
determined by trypan blue dye exclusion. Data
represent mean ± SD (n = 3). In all cases,
wild-type cells are represented by circles and
caspase-8 mutant cells by triangles. Open
symbols indicate untreated controls and filled
symbols indicate treated samples. DNA
laddering was also monitored to confirm
apoptosis in response to the various DNA-
damaging agents (data not shown).
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1% paraformaldehyde. Samples were analyzed on a FACScaliber
(Beckton Dickinson) using Cell Quest software.
Transfection and complementation
Jurkat cells were electroporated (0.4 cm cuvette, 250 V, 950 µF;
BioRad) with 20 µg DNA per transfection. pRSV-caspase-8 was con-
structed as follows. Total RNA from wild-type Jurkat cells was isolated
by Trizol and subjected to RT–PCR using primers specific for caspase-
8. The resulting PCR product was subcloned into pRSV using HindIII
and XbaI. After 1 h recovery, cells were spun over a Ficoll-plaque gradi-
ent (Pharmacia) to remove dead cells from the transfection procedure.
Each transfection was then divided in half and either left untreated or
treated with Fas antibody (ascites, 7C11 at 1:1000, gift from Michael J.
Robertson) for 12 h. Cells were then washed in FACS wash (0.5%
bovine serum albumin (BSA) in PBS) and stained with anti-CD8–FITC
(Collaborative Labs) at a 1:50 dilution. Propidium iodide (Sigma) was
added 5 min before FACS analysis at 40 µg/ml to detect dead cells.
Cells were analyzed on a FACScaliber using Cell Quest software.
In vitro protease assays
Protease assays were performed as described [34]. Briefly, Jurkat cells
were concentrated to 2 × 107 cells/ml in complete media and either left
untreated or treated with 250 ng/ml anti-Fas antibody (CH11) for various
times. Cells were washed twice with ice-cold RPMI and resuspended at
4 × 105 cells/µl in extraction buffer (10 mM HEPES pH 7, 2 mM MgCl2,
50 mM NaCl, 5 mM EGTA pH 7.6, 40 mM β-glycerophosphate, 1 mM
DTT, 1 mM PMSF, 1 µg/ml leupeptin, 1 µg/ml pepstatin). Cells were
lysed by four cycles of freeze–thawing in a dry ice/ethanol bath. Extracts
were centrifuged at 14,000 g for 15 min at 4°C and stored at –80°C.
The substrates pcDNA3–procaspase-2 and pBSII–PARP were tran-
scribed in vitro and translated and labeled with [35S]methionine using
TNT (Promega) for 90 min at 30°C. Cell extract (5 µl) was incubated
with 0.5–1.5 µl of the translation reaction for 1 h at 37°C. An equal
volume of 2 × sample buffer was added to stop the reaction. Cleavage
products were analyzed by SDS–PAGE and fluorography.
Protein kinase assays
Jurkat cells (2 × 106 cells/ml) were treated with Fas antibody
(250 ng/ml) for 2 h. Cells (3 × 106) were pelleted by pulse microcen-
trifugation, washed with cold PBS and lysed in lysis buffer as previ-
ously described [54]. Immune complex kinase assays were performed
as previously described [54], using rabbit polyclonal antisera to p38 or
anti-JNK-1 (Santa Cruz). GST–ATF2 (1–109) was used as substrate
[55]. Bacterial expression and purification of GST fusion proteins has
been described [56]. Kinase reactions were performed for 15 min at
30°C, stopped with an equal volume of 2 × sample buffer and analyzed
by SDS–PAGE and autoradiography. 32P incorporation into substrate
was quantitated with a Molecular Dynamics PhosphorImager using
ImageQuant software.
Western blot analysis
Western blot analysis was performed as previously described [39].
Total protein (20–30 µg) was analyzed by SDS–PAGE and transferred
to nitrocellulose membranes (Schleicher & Schuell). Membranes were
incubated with anti-MAP kinase (1:5000), anti-SHP-1 (1:1000), anti-
DAXX (1:100), anti-PARP (R&D Systems; 1:2500), anti-caspase-3
(1:2000), anti-PARP C2-10 (1:10,000) anti-PKC-δ (1:1000), anti-
caspase-2 (1:1000), anti-caspase-10 (1:1000) anti-Bcl-xL (1:1000),
anti-Bcl-2 (1:1000), anti-FADD (1:100) or anti-IκBα (1:1000) and visu-
alized with secondary antibody coupled to horseradish peroxidase
(Boehringer Mannheim), using enhanced luminol reagents (Renais-
sance; NEN).
UV irradiation
Jurkat cells (1 × 107) were washed once in 5 ml PBS, resuspended in
1.5 ml PBS, irradiated with UV-C (80 J/m2) in a Stratalinker (Stratagene),
washed in 5 ml PBS and transferred into complete media. At various
times after irradiation a sample was removed, washed in cold PBS and
analyzed on a FACScaliber using Cell Quest software. Propidium iodide
(Sigma) was added 5 min before FACS analysis at 40 µg/ml to identify
dead cells.
DNA laddering
Chromosomal DNA was isolated to assess the extent of oligonucleo-
somal cleavage using a modified protocol [57]. Briefly, 1 × 106 cells
were treated with various apoptotic agents, pelleted in a microfuge,
washed once in cold 1 × PBS and then lysed in 300 µl TENS (10 mM
Tris-HCl, pH 7.4, 1 mM EDTA, pH 7.4, 150 mM NaCl, 1% SDS) plus
0.2 mg/ml proteinase K. Digestion was allowed to proceed overnight
at 37°C. Lysate was then extracted twice with phenol:chloroform,
then once with chloroform. DNA was precipitated, dried in a speed-
vac and resuspended in 30 µl TE (10 mM Tris-HCl, pH 8, 1 mM
EDTA, pH 8) plus 0.5 mg/ml RNase A, and 15 µl was then analyzed
on a 1% TBE (0.045 M Tris-borate, 0.001 M EDTA) agarose gel elec-
trophoresed at 20–30 V.
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